Loading...
Loading...
CDC PLACES (2023, crude) estimates 8.1% of adults in Fargo have diagnosed diabetes — 3.9 points below the U.S. 12% figure. Census population 125,990. North Dakota Medicare wound biologics: Noridian Healthcare Solutions (JF). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Fargo clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Fargo storefront.
Orthobiologic Treatments for Your Practice in Fargo, ND for clinics & physicians. Premium orthobiologic tr… Compliance support & pricing — contact Hawk Medical.
Fargo is a city under 250k (125,990 Census). CDC PLACES (2023, crude) estimates 8.1% of adults in Fargo have diagnosed diabetes — 3.9 points below the U.S. 12% figure. Adult arthritis here is 21.2% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Orthobiologic Treatments for Your Practice notes (how the product actually works)CDC PLACES (2023, crude) estimates 8.1% of adults in Fargo have diagnosed diabetes — 3.9 points below the U.S. 12% figure. Adult obesity in Fargo is 34.3% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 21.2% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JF / Noridian Healthcare Solutions, sibling states AK, AZ, ID, MT, OR, SD, UT, WA, WY. North Dakota Health & Human Services is the public-health home. We will not mash those grains into a fake “demand score.”
Vendor consolidation is boring on purpose: one account, IFUs filed, JF articles mapped. 6.8% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 8.1% of adults — 3.9 points below the U.S. 12% figure. Obesity is 34.3%; arthritis is 21.2%. That is place-level BRFSS modeling, not a clinic census and not a Fargo trial.
CDC estimates 12% of the U.S. population has diabetes (40.1 million people, 2023). America's Health Rankings (BRFSS 2024) shows state adult rates from Colorado 8.4% to West Virginia 18.4%. We do not publish a made-up city diabetes count. Use national/state published rates plus your panel.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
We do not publish a consumer directory of every account. Patients should ask their current specialist whether the practice offers orthobiologic treatments for your practice and which products they use.
If you operate in North Dakota and another MAC state, say it on the first call. JF will not port 1:1. We would rather split utilization than watch a sister clinic copy Fargo tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Fargo, ND.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Fargo is JF geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Fargo — 3.9 points below the U.S. 12% figure. Planning input, not an outcomes claim.
North Dakota Part B wound biologics follow this contractor (siblings: AK, AZ, ID, MT, OR, SD, UT, WA, WY). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Fargo. Useful for joint-program math; still needs a diagnosis and privileging.
No Fargo storefront. Joe Bradley is an active practice owner. orthobiologic treatments stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.